Tilray Brands (TLRY) Amortizatization of Intangibles (2019 - 2026)
Tilray Brands (TLRY) posted Amortizatization of Intangibles of $2.0 million for Q1 2026, up 1.26% on a QoQ basis from $2.0 million in Q4 2025, and down 27.22% year-over-year from $2.8 million in Q1 2025.
Tilray Brands (TLRY) Amortizatization of Intangibles (2019 - 2026) Analysis & Trends
Tilray Brands' Amortizatization of Intangibles history runs 7 years deep, the most recent figure standing at $2.0 million for Q1 2026.
- Quarterly Amortizatization of Intangibles fell 27.22% year-over-year to $2.0 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was -$82.6 million (down 153.99% YoY) and the FY2025 annual result came in at $10.9 million, down 91.44% from the prior year.
- Amortizatization of Intangibles was $2.0 million for Q1 2026 at Tilray Brands, up from $2.0 million in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $115.4 million in Q2 2024 and bottomed at -$108.8 million in Q2 2022.
- A 5-year average of $2.3 million and a median of $2.9 million in 2024 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2024 — Amortizatization of Intangibles surged 218.64% — and 2025, when it slumped 176.7%.
- Tilray Brands' Amortizatization of Intangibles stood at $33.3 million in 2022, then plunged by 91.51% to $2.8 million in 2023, then advanced by 3.18% to $2.9 million in 2024, then sank by 31.89% to $2.0 million in 2025, then advanced by 1.26% to $2.0 million in 2026.
- Business Quant data shows TLRY's Amortizatization of Intangibles at $2.0 million in Q1 2026, $2.0 million in Q4 2025, and $2.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 1.30 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Tilray Brands | 454.65 Mn | 394.45 Mn | 54.95 Mn | 2.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 2.01 Mn |
| Feb 28, 2026 | 2.01 Mn |
| Nov 30, 2025 | 1.99 Mn |
| Nov 30, 2025 | 1.99 Mn |
| Aug 31, 2025 | 1.98 Mn |
| Aug 31, 2025 | 1.98 Mn |
| May 31, 2025 | -88.55 Mn |
| May 31, 2025 | -88.55 Mn |
| Feb 28, 2025 | 2.77 Mn |
| Feb 28, 2025 | 2.77 Mn |
| Nov 30, 2024 | 2.92 Mn |
| Nov 30, 2024 | 2.92 Mn |
| Aug 31, 2024 | 31.81 Mn |
| Aug 31, 2024 | 31.81 Mn |
| May 31, 2024 | 115.45 Mn |
| May 31, 2024 | 115.45 Mn |
| Feb 29, 2024 | 2.90 Mn |
| Feb 29, 2024 | 2.90 Mn |
| Nov 30, 2023 | 2.83 Mn |
| Nov 30, 2023 | 2.83 Mn |